In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19
Abstract Rapid generation of diagnostics is paramount to understand epidemiology and to control the spread of emerging infectious diseases such as COVID-19. Computational methods to predict serodiagnostic epitopes that are specific for the pathogen could help accelerate the development of new diagnostics. A systematic survey of 27 SARS-CoV-2 proteins was conducted to assess whether existing B-cell epitope prediction methods, combined with comprehensive mining of sequence databases and structural data, could predict whether a particular protein would be suitable for serodiagnosis. Nine of the predictions were validated with recombinant SARS-CoV-2 proteins in the ELISA format using plasma and sera from patients with SARS-CoV-2 infection, and a further 11 predictions were compared to the recent literature. Results appeared to be in agreement with 12 of the predictions, in disagreement with 3, while a further 5 were deemed inconclusive. We showed that two of our top five candidates, the N-terminal fragment of the nucleoprotein and the receptor-binding domain of the spike protein, have the highest sensitivity and specificity and signal-to-noise ratio for detecting COVID-19 sera/plasma by ELISA. Mixing the two antigens together for coating ELISA plates led to a sensitivity of 94% (N=80 samples from persons with RT-PCR confirmed SARS-CoV2 infection), and a specificity of 97.2% (N=106 control samples)..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 01. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Phan, Isabelle Q. [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| doi: |
10.1101/2020.05.22.111526 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI017997542 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI017997542 | ||
| 003 | DE-627 | ||
| 005 | 20231205150509.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200601s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.05.22.111526 |2 doi | |
| 035 | |a (DE-627)XBI017997542 | ||
| 035 | |a (biorXiv)10.1101/2020.05.22.111526 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Phan, Isabelle Q. |e verfasserin |0 (orcid)0000-0001-6873-3401 |4 aut | |
| 245 | 1 | 0 | |a In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Rapid generation of diagnostics is paramount to understand epidemiology and to control the spread of emerging infectious diseases such as COVID-19. Computational methods to predict serodiagnostic epitopes that are specific for the pathogen could help accelerate the development of new diagnostics. A systematic survey of 27 SARS-CoV-2 proteins was conducted to assess whether existing B-cell epitope prediction methods, combined with comprehensive mining of sequence databases and structural data, could predict whether a particular protein would be suitable for serodiagnosis. Nine of the predictions were validated with recombinant SARS-CoV-2 proteins in the ELISA format using plasma and sera from patients with SARS-CoV-2 infection, and a further 11 predictions were compared to the recent literature. Results appeared to be in agreement with 12 of the predictions, in disagreement with 3, while a further 5 were deemed inconclusive. We showed that two of our top five candidates, the N-terminal fragment of the nucleoprotein and the receptor-binding domain of the spike protein, have the highest sensitivity and specificity and signal-to-noise ratio for detecting COVID-19 sera/plasma by ELISA. Mixing the two antigens together for coating ELISA plates led to a sensitivity of 94% (N=80 samples from persons with RT-PCR confirmed SARS-CoV2 infection), and a specificity of 97.2% (N=106 control samples). | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Subramanian, Sandhya |4 aut | |
| 700 | 1 | |a Kim, David |4 aut | |
| 700 | 1 | |a Carter, Lauren |4 aut | |
| 700 | 1 | |a King, Neil |4 aut | |
| 700 | 1 | |a Anishchenko, Ivan |4 aut | |
| 700 | 1 | |a Barrett, Lynn K. |4 aut | |
| 700 | 1 | |a Craig, Justin |4 aut | |
| 700 | 1 | |a Tillery, Logan |4 aut | |
| 700 | 1 | |a Shek, Roger |4 aut | |
| 700 | 1 | |a Harrington, Whitney E. |4 aut | |
| 700 | 1 | |a Koelle, David M. |4 aut | |
| 700 | 1 | |a Wald, Anna |4 aut | |
| 700 | 1 | |a Boonyaratanakornkit, Jim |4 aut | |
| 700 | 1 | |a Isoherranen, Nina |4 aut | |
| 700 | 1 | |a Greninger, Alexander L. |4 aut | |
| 700 | 1 | |a Jerome, Keith R. |4 aut | |
| 700 | 1 | |a Chu, Helen |4 aut | |
| 700 | 1 | |a Staker, Bart |4 aut | |
| 700 | 1 | |a Stewart, Lance |4 aut | |
| 700 | 1 | |a Myler, Peter J. |0 (orcid)0000-0002-0056-0513 |4 aut | |
| 700 | 1 | |a Van Voorhis, Wesley C. |0 (orcid)0000-0001-6141-2015 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 01. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:01 |g month:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41598-021-83730-y |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.05.22.111526 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 01 |c 10 | ||